n-methyladenosine has been researched along with Ovarian Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 11 (91.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Li, F; Li, X; Wang, S; Xu, H; Yan, L; Zhu, L | 1 |
| Nie, X; Tan, J | 1 |
| Ding, H; Li, P; Luo, Y; Lyu, Y; Ni, G; Wang, Y; Zhang, Y | 1 |
| Cardenas, H; Huang, H; Matei, D; Valdivia, AF; Wang, Y; Zhao, G | 1 |
| Cheng, C; Jin, J; Li, L; Liu, T; Liu, Y; Luo, Q; Pi, J; Rao, S; Si, Y; Wang, F; Wei, Q; Xiao, H; Yang, Y; Yi, P; Yu, J; Zou, D | 1 |
| Cardenas, H; Chaparala, A; Chen, J; Davuluri, RV; Huang, H; Ji, Y; Kandpal, M; Matei, D; Tanner, EJ; Wang, Y; Zhao, G | 1 |
| Huang, Y; Wang, Q; Zhang, J; Zhang, Q | 1 |
| Li, Q; Wang, Q; Zhang, J; Zhang, Q | 1 |
| Cheng, J; Li, J; Ni, M; Wang, S; Wu, X; Xu, F; Zhao, H; Zhou, X | 1 |
| Jiang, L; Jiao, J; Luo, Y | 1 |
| Guan, Q; Guo, H; Hong, D; Ji, J; Liu, J; Ren, Q; Zhang, C; Zhang, Q | 1 |
| Bley, N; Chen, J; Dahl, A; Fuchs, T; Glaß, M; Haase, J; Huang, H; Hüttelmaier, S; Lederer, M; Müller, S; Posern, G; Singh, AK | 1 |
12 other study(ies) available for n-methyladenosine and Ovarian Neoplasms
| Article | Year |
|---|---|
Multiomics analysis identifies key genes and pathways related to N6-methyladenosine RNA modification in ovarian cancer.
Topics: Adenosine; Computational Biology; Databases, Genetic; DNA Copy Number Variations; Female; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Middle Aged; Mutation; Ovarian Neoplasms; Platelet Activation; Ribosomal Protein S6 Kinases, 90-kDa; RNA Processing, Post-Transcriptional | 2021 |
N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer.
Topics: Adenosine; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Ovarian Neoplasms; Prognosis; RNA, Long Noncoding | 2022 |
HIF-1
Topics: Adenosine; Cell Cycle Proteins; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; MicroRNAs; Ovarian Neoplasms; RNA Splicing Factors; RNA-Binding Proteins | 2022 |
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Female; Humans; Nicotinamide N-Methyltransferase; Ovarian Neoplasms; Platinum; RNA | 2023 |
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Topics: Adenosine; Animals; Carcinogenesis; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Eukaryotic Initiation Factor-3; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogenes; Ovarian Neoplasms; Protein Biosynthesis; RNA-Binding Proteins; RNA, Messenger | 2020 |
FTO-Dependent
Topics: 3' Untranslated Regions; Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Alternative Splicing; Animals; Ascites; Carcinogenesis; Cell Line, Tumor; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Down-Regulation; Fallopian Tubes; Female; Gene Knockdown Techniques; Heterografts; Humans; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Ovarian Neoplasms; Ovary; RNA Stability; RNA, Messenger; Second Messenger Systems; Sequence Analysis, RNA; Spheroids, Cellular; Tissue Array Analysis; Transcriptome; Tumor Suppressor Proteins | 2020 |
m
Topics: Adenosine; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Female; HeLa Cells; Humans; Methyltransferases; Ovarian Neoplasms; Uterine Cervical Neoplasms | 2020 |
Clinicopathological and immunological characterization of RNA m
Topics: Adenosine; Biomarkers, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Nerve Tissue Proteins; Nuclear Proteins; Ovarian Neoplasms; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA-Binding Proteins | 2021 |
FBW7 suppresses ovarian cancer development by targeting the N
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; F-Box-WD Repeat-Containing Protein 7; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Prognosis; RNA Stability; RNA-Binding Proteins; Sequence Analysis, RNA | 2021 |
N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex alpha Subunits; Adenosine; Angiotensin-Converting Enzyme 2; Carcinoma, Ovarian Epithelial; CD79 Antigens; Cell Cycle Proteins; Female; Filaggrin Proteins; GTP Phosphohydrolases; Histone Deacetylase 1; Homeodomain Proteins; Humans; Membrane Proteins; Ovarian Neoplasms; Prognosis; Proportional Hazards Models; Receptors, G-Protein-Coupled; Repressor Proteins; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA, Messenger; Sodium-Bicarbonate Symporters; Survival Rate; Transcription Factors; Transcriptome | 2021 |
m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
Topics: Adenosine; Databases, Genetic; Female; Gene Regulatory Networks; Humans; Methylation; Neoplasm Invasiveness; Ovarian Neoplasms; Prognosis; RNA; Transcriptome | 2021 |
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.
Topics: Adenosine; Animals; Cell Line, Tumor; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mice; MicroRNAs; Ovarian Neoplasms; RNA-Binding Proteins; Serum Response Factor; Xenograft Model Antitumor Assays | 2019 |